Zydus Lifesciences Limited

NSE: ZYDUSLIFEHealthcareLot size: 900

Zydus Lifesciences Limited Open Interest & PCR Analysis

₹1120.00Updated 4 Sept 2026, 03:30 pm IST
PCR
0.52Bearish signal
Max Pain
₹1150Spot below by ₹30
Total CE OI
4.64MCall writers
Total PE OI
2.39MPut writers
OI Buildup Signal
Neutral
Price movement < 0.3% threshold
Put-Call Ratio Gauge
0 — Bearish1.0 — Neutral2.0+ — Bullish
AI AnalysisGenerated daily after market close · AI-powered

OI Buildup Pattern

The build‑up is classified as neutral, meaning that price has moved flat while open interest (OI) remains unchanged. This pattern suggests an equilibrium between new contracts and expiries, with neither long nor short side gaining a decisive edge. Consequently, market participants are not markedly adding to or unwinding positions for this expiry.

Put‑Call Ratio

The put‑call ratio (PCR) stands at 0.516, indicating a modest bias toward calls relative to puts. Yesterday’s PCR was 0.541, showing a slight reduction in the relative weight of puts on a day‑over‑day basis.

Futures OI

Futures open interest registers zero change for the current expiry, implying that the total number of contracts outstanding is stable. The lack of OI movement points to an absence of significant fresh positioning or large‑scale exits among futures traders.

Data Summary

The key open‑interest figure for this expiry is a total CE OI of 4,641,300 contracts, with PE OI at 2,394,000.

Data as of 2026-09-04

Frequently Asked Questions

What is Zydus Lifesciences Limited PCR (Put-Call Ratio) today?
Zydus Lifesciences Limited's current PCR is 0.52. A PCR above 1.2 is considered bullish (more put writing = floor support); below 0.8 is bearish; 0.8–1.2 is neutral. Zydus Lifesciences Limited's PCR of 0.52 indicates bearish sentiment.
What is Zydus Lifesciences Limited OI buildup type today?
Zydus Lifesciences Limited is currently showing neutral positioning with no significant directional bias. This is determined by comparing today's price change direction with the direction of total OI change — using the standard F&O buildup classification framework.
What is total CE and PE open interest for Zydus Lifesciences Limited?
Zydus Lifesciences Limited has total CE (call) OI of 4641300 contracts and total PE (put) OI of 2394000 contracts for the nearest expiry. The PCR is 0.52.
How is open interest analysis useful for Zydus Lifesciences Limited trading?
OI analysis for Zydus Lifesciences Limited helps identify institutional positioning. High CE OI at a strike = call writers defending that level (resistance). High PE OI = put writers defending that level (support). The buildup type tells you whether smart money is building fresh positions (bullish/bearish) or exiting existing ones.
What is the max pain for Zydus Lifesciences Limited?
Zydus Lifesciences Limited's max pain is ₹1,150 — the strike price where option writers (sellers) collectively suffer the least financial loss at expiry. The current spot price vs max pain deviation guides near-term directional bias into expiry.